FDA Registered 503B Outsourcing Facility

White Paper: The Importance of cGMP (503B) Compounded Drugs

503A versus 503B: What’s the difference? When it comes to compounded drugs, a facility’s compliance with current good manufacturing practices (cGMP) largely impacts both healthcare professionals and patients.

In this free white paper, we take a deeper look at the differences between these two types of outsourcing facilities. Submit the form to get your copy of the complete white paper.

Get the White Paper: